Trials / Completed
CompletedNCT03791489
Multi-Treatment PNN Modulation for Chronic Rhinitis
Feasibility Study of Multi-Treatment Posterior Nasal Nerve (PNN) Modulation for Treatment of Chronic Rhinitis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Arrinex, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility of treatment at multiple sites with the ClariFix cryoablation device for treatment of chronic rhinitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ClariFix | The ClariFix™ device (K162608) is an FDA 510(k) cleared Class II cryosurgical tool indicated for the destruction of unwanted tissue during surgical procedures, including in adults with chronic rhinitis. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2019-07-18
- Completion
- 2019-07-18
- First posted
- 2019-01-02
- Last updated
- 2020-07-24
- Results posted
- 2020-07-24
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03791489. Inclusion in this directory is not an endorsement.